Kairos Pharma Ltd. (KAPA)
0.505
+0.03
(+6.65%)
USD |
NYAM |
Nov 03, 16:00
0.486
-0.02
(-3.76%)
After-Hours: 20:00
Kairos Pharma Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 66.41% |
| Anika Therapeutics, Inc. | 83.15% |
| Savara, Inc. | 93.79% |
| Vericel Corp. | 73.97% |